Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance
Pharmaceutical Technology
SEPTEMBER 7, 2022
Pharmacovigilance refers to the practice of collecting, detecting, assessing, monitoring and preventing adverse effects (AEs) caused by new drug substances. After AEs are recorded, they must be translated and put back out to doctors and scientists for processing. Adapting pharmacovigilance to deal with surging case reports.
Let's personalize your content